10/25/12
In the article I read from BBC news, there are major
concerns about the financing of drugs that prevent and treat Malaria. The
Affordable Medicines Facility for Malaria or the AMFm has no hard evidence that
their efforts are saving lies of the dying people. With this in thought, places
like the UK are threatening to take away their funding for Malaria medicines
that go out to other countries such as Ethiopia and Nigeria. On the other hand, the AMFm says that a study
shows that they are lowering drug prices for usually high priced good drugs.
With over 200million people contracting malaria each year and 665 thousand
dying as a result each year, the funding for these malaria prevention and
treatment facilities is quite controversial. Oxfam believes that by keeping the
AMFm active it is dangerous economically since the global budget will be
investing so much money but not knowing if it is a worthwhile investment since
there is no proof of the AMFm’s outcomes. Additionally some western aid groups
refuse approaches that have any involvement with private sectors. In reality,
the programs getting the life saving treatments are supplying the people who
need it most where they are already looking for treatment options. In my opinion I believe the AMFm has to have at
least some type of benefit to the treatment and prevention of malaria. I
believe that it should continue to be funded regardless from where or who
because the ultimate goal is to bring medicine to those around the world with
restricted access and to save the lives of people who may die of something that
is curable/treatable.
No comments:
Post a Comment